Application of medical imaging in ovarian cancer: a bibliometric analysis from 2000 to 2022 Authors: Yinping Leng, Shuhao Li, Jianghua Zhu, Xiwen Wang, Fengyuan Luo, Yu Wang, Lianggeng Gong Published: 2023 ABSTRACT BackgroundOvarian cancer (OC) is the most lethal tumor within the female reproductive system. Medical imaging plays a significant role in diagnosis and monitoring OC. This study aims to use bibliometric analysis to explore the current research hotspots and collaborative networks in the application of medical imaging in OC from 2000 to 2022.MethodsA systematica search for medical imaging in OC was conducted on the Web of Science Core Collection on August 9, 2023. All reviews and articles published from January 2000 to December 2022 were downloaded, and an analysis of countries, institutions, journals, keywords, and collaborative networks was perfomed using CiteSpace and VOSviewer.ResultsA total of 5,958 publications were obtained, demonstrating a clear upward trend in annual publications over the study peroid. The USA led in productivity with 1,373 publications, and Harvard University emerged as the most prominent institution with 202 publications. Timmerman D was the most prolific contributor with 100 publications, and Gynecological Oncology led in the number of publications with 296. The top three keywords were “ovarian cancer” (1,256), “ultrasound” (725), and “diagnosis” (712). In addition, “pelvic masses” had the highest burst strength (25.5), followed by “magnetic resonance imaging (MRI)” (21.47). Recent emergent keywords such as “apoptosis”, “nanoparticles”, “features”, “accuracy”, and “human epididymal protein 4 (HE 4)” reflect research trends in this field and may become research hotspots in the future.ConclusionThis study provides a comprehensive summary of the key contributions of OC imaging to field’s development over the past 23 years. Presently, primary areas of OC imaging research include MRI, targeted therapy of OC, novel biomarker (HE 4), and artificial intelligence. These areas are expected to influence future research endeavors in this field. Introduction Ovarian cancer (OC) is the most lethal tumor of the female reproductive system (1). The absence of early clinical manifestations and effective screening techniques contributes to approximately 70% of patients being diagnosed at an advanced stage (2). The primary therapeutic approach for OC involves a combination of cytoreductive surgery and adjuvant chemotherapy (3). Despite notable advancements in chemotherapy and targeted therapy for OC, the prognosis remains unfavorable, with a 5-year overall survival rate ranging from 40% to 45% (4). Medical imaging, such as computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET)/CT, has been extensively employed for preoperative diagnosis, staging, treatment guidance, and prognostic assessment of OC (5–7). The utilization of medical imaging holds promise in enhancing the survival rate of OC patients through early detection and intervention (8). Over the past few decades, there has been a notable surge in the volume of scholarly publications pertaining to OC imaging across diverse academic domains (9). However, in the extensive literature database, it is often challenging for researchers to obtain a comprehensive and updated overview of the research trends and hotspots in this field. Mathematical and statistical techniques are employed in bibliometrics to analyze published research regarding a specific subject area (10). This methodology allows not only the evaluation of research quality but also the identification of developing research trends and the prediction of possible future research directions (11, 12). Previous studies have utilized bibliometric analysis to examine prominent research topics and studies concerning OC (13–15). Duan’s research revealed that platinum-resistant OC is primarily focused on identifying populations that can benefit from immunotherapy alongside the practical implementation of immune checkpoint inhibitors (13). Baghban’s findings indicated an increasing trend in the research of extracellular vesicles and epithelial ovarian cancer (14). Conducting bibliometric analysis of literature pertaining to OC from various perspectives can aid in identifying research priorities within this domain while also presenting academic researchers with opportunities for collaboration (16, 17). However, the current research status, development trends, and future research directions of OC imaging are still unclear. This study aims to use CiteSpace and VOSviewer for visual analysis, evaluate the current research status and development trends of OC imaging, and determine and summarize future research directions in this field. Materials and methods Data sources and search strategy We conducted a literature search on August 9, 2023, to retrieve published literature from January 2000 to December 2022 from the Science Citation Index-Expanded (SCIE) of the Web of Science Core Collection (WoSCC). To avoid the bias of database updates, all searches were performed on the same day. The search strategy used was as follows: (TS = ((“ovarian neoplasm*”) OR (“ovarian cancer*”) OR (“ovarian carcinoma”) OR (“ovary cancer*”) OR (“ovary tumo*”) OR (“ovary neoplasm*”) OR (“ovary carcinoma”) OR (“ovarian tumo*”) OR (“cancer of ovary”) OR (“ovarian malignan*”) OR (“malignant ovarian*”)) AND TS = ((“CT”) OR (“computed tomography”) OR (“compute tomography”) OR (“magnetic resonance imaging”) OR (“MRI”) OR (“MR”) OR (“positron emission tomography”) OR (“PET”) OR (“single photon emission computed tomography”) OR (“SPECT”) OR (“ultrasonography”) OR (“ultrasound”))) AND FPY=(2000-2022). This study included only “articles” and “reviews” as publication types to ensure representativeness. Moreover, only documents written in English were considered. Two reviewers (YL and XW) independently screened the raw data extracting publications from WoSCC and eliminating duplicate/irrelevant documents. In cases of discrepancies, a third reviewer (LG) independently helped resolve them. The data were saved as a text file with Full Record and Cited References. A total of 5,958 publications were prepared for subsequent visual analysis. The study flowchart is presented in Figure 1 . All data in this study were directly obtained from the database, and as no patients were involved, ethical declarations or approvals are not applicable. Flow chart of this study. Data analysis and visualization The bibliometric indicators included Price’s law, Lotka law, and Bradford’s law. Price’s law, a bibliometric production indicator, measures the productivity of a discipline or a country (18). Lotka uses the number of articles published to describe the frequency distribution of scientific productivity, often referred to as the “inverse square law of scientific production” (19). Bradford’s law, another bibliometric indicator, measures the dispersion of scientific information, illustrating the distribution of scientific literature within specific disciplines (20). Bradford proposed an information density-decreasing concentric zone productivity model. The number of annual publications was imported into Excel 2019 and further analyzed to identify trends. CiteSpace (version 6.2.R4) was used to create knowledge maps of journals, institution co-authorship, references co-occurrences, and keyword co-occurrences. Time slices were set to 1 year per slice, and the g-index was selected as criteria for selection. The network pruning method was used for pruning. In the visual network maps, the size of nodes reflects the number of publications or the frequency of citations, while the connections between nodes indicate the strength of the connections. To detect emerging trends and sudden changes in research frontiers, the software’s “burst detection” and “betweenness centrality” functions were applied. Betweenness centrality is an index based on tree hole theory that measures the centrality of nodes in a network (21). Using CiteSpace with this index, the importance of relevant literature was measured, and purple circles indicated nodes with centrality greater than 0.1. The analysis of countries, co-cited countries, and co-cited institutions were performed using VOSviewer (version 1.6.19). Nodes and linear connections were present in the visual knowledge graph. Nodes in the graph represent key points, and node size represents the frequency of occurrence and citation. Results This study examined 5,958 publications, including 5,299 articles (88.9%) and 659 reviews (11.1%). Our investigation showed that 26,643 authors from 3,958 institutions across 84 countries contributed to the production of 5,958 manuscripts in this study. These works were published in 1,186 journals, citing 126,115 references from 12,959 journals. Trends in publications To comprehend the evolution of related research, we examined the annual publication trends. The study period exhibited a discernible upward trajectory in annual publications ( Figure 2 ). Moreover, the analysis indicated an average yearly production was around 259 studies, with 2022 recording the highest number of publications. Figure 2 also illustrates the change in cumulative publications along the trend line, which followed the equation y = 268.49e0.1505x, with a correlation coefficient of 0.970, in accordance with Price’s law of exponential growth. The doubling time was determined to be 4.61 years, and the annual growth rate was 16.24%. The number of publications and cumulative publications on ovarian cancer imaging from January 2000 to December 2022. Yearly publication count (y=268.49e0.1505x, r=0.970, where y is the cumulative publication number and x is the publication year). We used Lotka law to analyze the distribution of the authors and found that most of them were small producers, with a high transience index (occasional authors) of 76.5 ( Supplementary Table 1 ). Bradford’s model was applied to assess the distribution of scientific journals publishing papers on OC imaging, as detailed in Supplementary Table 2 delineating the material into Bradford’s zones. Analysis of countries and institutions The publications identified came from 84 countries, with the USA leading in the number of studies (1,373 publications), constituting 23.04% of all documents. Subsequent top contributors included China (903 publications), Japan (417 publications), and Italy (402 publications) ( Table 1 ). Among the 1,373 papers published in the USA, 1,116 were solely authored by individuals from the USA, while the remaining 257 papers involved collaborations with other countries. Supplementary Figures 1A and B display the cooperative relationships among countries and cited countries in OC imaging. Table 1Top 15 countries/regions in the ovarian cancer imaging research.RankCountry/regionCountsPercentage(%)SCPMCPCited country/regionCitationsAverage Citations1USA137323.041116257USA60347442China90315.1682479United Kingdom1485742.83Japan4177.0040215China1183313.14Italy4026.75288114Italy1018125.35United Kingdom3475.82243104Germany788843.36Korea2133.5819914Japan740717.87Germany1823.0513448Netherlands632644.58France1682.8211949Belgium561356.19Turkey1502.521428Canada519641.610Netherlands1422.389646France476228.311Canada1252.108936Korea429520.212Spain1181.987147Switzerland398455.313India1121.888725Australia384737.714Poland1031.738320Spain262222.215Australia1021.717131India232420.8SCP, the number of co-authored papers by authors of the same nationality; MCP, the number of co-authored papers with authors from others countries. Top 15 countries/regions in the ovarian cancer imaging research. SCP, the number of co-authored papers by authors of the same nationality; MCP, the number of co-authored papers with authors from others countries. Research in OC imaging involved 3,958 institutions. The three institutions that had the most publications were Harvard University (USA, 202 publications), the University of London (United Kingdom, 190 publications), and the University of Texas System (USA, 168 publications) ( Table 2 ). The institution with the highest centrality was the University of London (0.11), which indicates that this institution plays a crucial bridging role in research in this field. Supplementary Figure 1C shows the cooperative relationships among institutions in OC imaging. Table 2Top 15 institutions in the ovarian cancer imaging research.RankInstitutionCountryCountCentralityYear1Harvard UniversityUSA2020.0620002University of LondonUnited Kingdom1900.1120003University of Texas SystemUSA1680.0220004Catholic University of the Sacred HeartItaly1380.0120055IRCCS Policlinico GemelliItaly1380.0120056KU LeuvenBelgium1350.0820037UTMD Anderson Cancer CenterUSA1340.0320008Memorial Sloan Kettering Cancer CenterUSA1330.0720009UDICE-French Research UniversitiesFrance1270.05200410University of California SystemUSA1120.09200011Harvard Medical SchoolUSA1060.02200012Imperial College LondonUnited Kingdom1020.06200613Fudan UniversityChina970201214National Institutes of HealthUSA950.07200015University College LondonUnited Kingdom950.022006 Top 15 institutions in the ovarian cancer imaging research. Analysis of authors and co-cited authors The total number of authors across 5,958 publications was 26,643, yielding a co-authorship index of 4.47. Table 3 shows the top 15 authors and co-cited authors. Timmerman D led in publications (100), followed by Testa AC (83) and Valentin L (77). Timmerman D also emerged as the most co-cited author (2,650 citations, H_index: 40), followed by Valentin L (2,248 citations, H_index: 36) and Van Holsbeke C (1,547 citations, H_index: 31). Table 3Top 15 authors and co-cited authors in the ovarian cancer imaging research.RankAuthorCountsH_indexCo-cited authorCitationsH_index1Timmerman D10040Timmerman D2650402Testa AC8330Valentin L2248363Valentin L7736Van Holsbeke C1547314Scambia G6021Vergote I1478335Alcazar JL5524Testa AC1466306Guerriero S5526Bourne T1425307Van Holsbeke C5531Van Calster B1354298Bourne T5130Guerriero S1004269Menon U5026Van Huffel S9582010Vergote I5033Jurkovic D9512211Sala E4823Hricak H8281912Dyson PJ4726Fischerova D8092313Fischerova D4523Savelli L7932114Wang Y3913Fruscio R7021815Van Calster B3829Kaijser J64716 Top 15 authors and co-cited authors in the ovarian cancer imaging research. Analysis of active journals A total of 1,186 journals contributed to this topic. Table 4 outlines the top 15 journals in OC imaging, with Gynecologic Oncology leading in publications [296 publications, Impact factor (IF): 5.3], trailed by the International Journal of Gynecological Cancer (182 publications, IF: 4.66). Journal of Clinical Oncology claimed the highest IF (50.72). The top 15 cited journals are shown in Table 4 . Gynecologic Oncology also had the most citations (12,493 citations), followed by Journal of Clinical Oncology (6,104 citations) and Radiology (5,284 citations). Figure 3 shows a dual-map overlay of the citing and cited journals in OC imaging research. The left labels were the citing journals, and the right labels were the cited journals. These labels represented the disciplines covered by the journals. There are three main citation paths, are highlighted in yellow and green. The yellow path indicated that studies from the molecular, biology, and genetics journals were cited in studies from the molecular, biology, and immunology journals. The two green paths indicated that studies from the molecular/biology/genetics and health/nursing/medicine journals were cited in studies from the medicine/medica/clinical journals. Table 4The top 15 journals and cited journals related to ovarian cancer imaging.RankJournalCountsCitationsIF (2022)Cited journalsCitationsCentrality1Gynecologic Oncology296124935.30Gynecologic Oncology124930.282International Journal of Gynecological Cancer18241104.66Journal of Clinical Oncology61040.153European Journal of Gynaecological Oncology1536210.26Radiology52840.144Ultrasound in Obstetrics & Gynecology14438438.68International Journal of Gynecological Cancer41100.035European Radiology6622347.03Obstetrics Gynecology34740.016Medicine631981.82American Journal of Obstetrics and Gynecology27960.037Journal of Nuclear Medicine61277211.08New England Journal of Medicine26940.028Journal of Clinical Oncology60610450.72Cancer22980.039Journal of Ovarian Research594765.51Cancer Research13620.1710PLoS One5910833.75American Journal of Roentgenology13510.0511Archives of Gynecology and Obstetrics585762.49British Journal of Cancer13380.1112Journal of Obstetrics and Gynecology Research583001.69Clinical Cancer Research12450.1113Radiology58528429.15CA-A Cancer Journal for Clinicians11920.0214Anticancer Research568732.44Lancet11290.0815Frontiers in oncology503015.74European Journal of Cancer11070.04IF, impact factor. The top 15 journals and cited journals related to ovarian cancer imaging. IF, impact factor. The dual-map overlay of journals related to ovarian cancer imaging research. The left side has the citing journals, and the right has the cited journals. The color of the path indicates the citation relationship. In the citing map, the length of the ellipse’s vertical axis reflects the number of papers published by the journal, and the length of the ellipse’s horizontal axis reflects the number of authors in the journal. Analysis of cited references The references with the most citations are often considered foundational to research in a specific field. Table 5 shows the top 15 co-cited references in OC imaging research. As mentioned above, the article “Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis Group” by Timmerman D published in Ultrasound In Obstetrics & Gynecology, was the most cited reference (298 citations). Figure 4 provides a timeline view of the co-cited references. The largest cluster was “#0 breast cancer”, followed by “#1 clinical practice guideline”, and “#2 advanced high-grade serous ovarian carcinoma”. The timeline shows that “#0 breast cancer” and “#10 rsna refresher courses” constituted the earliest clusters. Additionally, it is noteworthy that “#2 advanced high-grade serous ovarian carcinoma”, “#4 adnexal masses” and “#9 two-sample mendelian randomization study” became the most popular research topics in recent years. Five out of the 13 clusters are still active, suggesting that these research directions remain vibrant and represent ongoing hotspots in OC imaging. Table 5The top 15 co-cited references in the ovarian cancer imaging research.RankTitleFirst authorJournalYearCitations1Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group.Timmerman DUltrasound In Obstetrics & Gynecology20002982A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer.Jacobs IBritish Journal ofObstetrics andGynaecology19902783Cancer statistics, 2019.Siegel RLCA-A Cancer Journal For Clinicians20212754Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis.Bristow R EJournal of ClinicalOncology20021945Simple ultrasound-based rules for the diagnosis of ovarian cancer.Timmerman DUltrasound In Obstetrics & Gynecology20081866Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.Vergote INew EnglandJournal of Medicine20101717Transvaginal sonographic characterization of ovarian disease: evaluation a new scoring system to predict ovarian malignancy.Sassone A MObstetrics andgynecology19911488Staging of advanced ovarian cancer: comparison of imaging modalities–report from the Radiological Diagnostic Oncology Group.Tempany CMRadiology20001449Peritoneal Metastases: Detection with Spiral CT in Patients with Ovarian Cancer.Fergus VRadiology200213710A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography.Bristow RECancer200012611Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening.Menon ULancet Oncology200912512Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.Buys SSJAMA-Journal of the American Medical sociation201112413Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses.Tingulstad SBritish Journal ofObstetrics andGynaecology199612314New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).Eisenhauer EAEuropean Journal of Cancer200911815A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass.Moore RGGynecologic Oncology2009117 The top 15 co-cited references in the ovarian cancer imaging research. Timeline view of reference. In the timeline view, different colors of nodes on the same line indicate different years. Therefore, the nodes on the left represent older references, while the nodes on the right represent more recent references. A straight line in the same horizontal position indicates the set of all clustered references belonging, and the cluster label is located at the line’s rightmost end. The first cluster label on the knowledge map was “#0 breast cancer” and the second cluster label was “#1 clinical practice guideline”. Node size represents co-citation frequency, and the links between nodes indicate co-citation relationships. The occurrence year of each node indicates the initial co-citation time. Analysis of keywords Keywords can summarize the main content of publications and exploring the frontiers of OC imaging research. To enhance the relevance to this study, the selection of keywords excluded “cancer” and “carcinoma”. The top 15 keywords in OC imaging research are shown in Supplementary Table 3 . The keyword “ovarian cancer” (1,256), followed by “ultrasound” (725), “diagnosis” (712) with the highest frequency. Figure 5A shows a collaboration network of keywords created by VOSviewer. The research direction grouped the keywords and roughly divided them into 6 categories: the red cluster was the largest one, primarily focused on radiotherapy, chemotherapy, and anticancer treatment of OC. The green cluster was involved with the initial surgical evaluation of epithelial ovarian cancer and the prognostic evaluation of ovarian cancer with CT and PET/CT. The dark-blue cluster involved the risk factors of women suffering from OC and the diagnosis of OC related to breast cancer. The purple cluster was associated with the ovarian cancer risk of malignant index (RMI), and the ultrasound evaluation adnexal quality score. The yellow cluster was mainly related to the diagnosis and differential diagnosis of ovarian cancer. The baby-blue cluster was associated with the radiomics and deep learning research in ovarian cancer. Figure 5B displays the top 25 keywords with the highest burst strength in OC imaging research. “pelvic masses” had the highest burst strength (25.5), followed by “MRI” (21.47), which extends until 2022. “positron emission tomography” had the longest duration, from 2002 to 2011. Human epididymis protein 4 (HE 4) was a new keyword starting in 2020, with an burst strength of 9.51. Recently, popular keywords such as “apoptosis”, “nanoparticles”, “features”, “accuracy”, and “HE 4” reflect research trends in this field and may become research hotspots in the future. Analysis of ovarian cancer imaging-related keyword. (A) The co-occurrence network of keywords in VOSviewer. The figure displays the keywords that occurred more than 20 times. The nodes with different colors represent the keywords from different clusters, and the size of the nodes reflects their frequency. (B) The 20 keywords with the highest citation bursts in ovarian cancer imaging research. The red bold line indicates the years of citation bursts. (C) Timeline analysis of the keywords related to ovarian cancer imaging. The first cluster label on the knowledge map was “#0 cytotoxicity” and the second cluster label was “#1 positron emission tomography”. Each keyword cluster had its own timeline. Each node represents a keyword, which was marked under the node. The order in which nodes appear indicates the development and evolution process of keywords under clustering. Using the timeline viewer for keywords analysis reveals evolving hotspots in the field over time. The most common keywords for each group over time were shown by the timeline graph in CiteSpace ( Figure 5C ). The earliest and largest cluster was “#0 cytotoxicity”. Among the earliest keywords in this field were “carboplatin” and “crystal-structure”, while “DNA damage” and “acid” were the latest research targets in this area. The “#1 positron emission tomography” cluster was another large cluster that emerged earlier. Research frontiers in this field were keywords such as “anticancer activity” and “cisplatin resistance”. In addition, five of the 14 clusters are still active, including, “#3 risk of malignancy index”, “#4 peritoneal carcinomatosis”, “#5 risk”, “#6 logistic regression models”, “#13 women”, and “#14 ovarian cancer”, indicating that relevant research continues to progress in these specific areas. Discussion General information In this study, we conducted a systematic and comprehensive bibliometric analysis of research on OC medical imaging from January 1, 2000 to December 31, 2022. The number of annual publications showed a clear upward trend for OC imaging studies, indicating the sustained and significant attention this field has received in recent years. This study provides an overview of the medical imaging applications of ovarian cancer, helping researchers in understanding the current status, collaborative networks, and primary research hotspots in this field. In addition, our research findings provide a series of suggestions for future investigation. To promote teamwork and global collaboration in this area, we analyzed the distribution of countries/regions and institutions. Of the 5,958 publications, 23.04% were completed by researchers in the USA. China, as the only developing country in the top five productivity rankings, held the second position in OC imaging research output, following the USA. Moreover, seven of the 15 most productive institutions were in the USA. Harvard University, affiliated with the USA, having the most publications and the highest attention level. Therefore, the USA made a significant contribution to the academic influence and reputation of OC imaging research. While the University of London did not have the highest number of publications, it demonstrated the highest centrality, indicating its important bridging role in inter-country cooperation. Analyzing journals and co-cited journals can assist researchers in choosing suitable journals for their papers. The majority of papers were published in Gynecological Oncology, International Journal of Gynecological Cancer, and European Journal of Gynecological Oncology, all belonging to the gynecological and oncology fields. Meanwhile, Gynecological Oncology and Journal of Clinical Oncology stood out as the most cited journals. The degree of correlation between studies can be measured by references cited by other publications together. Co-citation analysis can help researchers identify the common knowledge bases shared by multiple studies efficiently and conveniently (22, 23). Analyzing the most co-cited references, reveals that advanced high-grade serous ovarian cancer and adnexal masses are important research foundations for OC imaging. Belgian researcher Timmerman D played a pivotal role by first standardizing the terminology, definitions, and measurements for describing sonographic features of adnexal masses (24). Several scholars have investigated the combination of ultrasound and cancer antigen 125 (CA125) to evaluate the malignancy risk index of advanced OC, which has yielded positive outcomes (25, 26). Subsequently, researchers explored the treatment of advanced OC (27, 28). During the platinum era, maximal cytoreductive surgery emerged as one of the most important determinants of survival in stage III or IV OC patients (27). Among them, Vergote I’s article, which was published in the journal New England Journal of Medicine, reported that the survival time of interval debulking surgery following neoadjuvant chemotherapy was not inferior to that of chemotherapy after maximal cytoreductive surgery in patients with stage IIIC or IV OC (28). Current research status of imaging in OC CT is the recommended imaging technique for staging OC. The overall accuracy of CT for diagnosis of malignant ovarian masses is reported to be as high as 89%. However, the sensitivity and specificity of CT in diagnosing malignant abdominal lymph nodes were 41% and 89% (29). A recent meta-analysis showed that CT’s sensitivity, specificity, and diagnostic advantage rate in detecting peritoneal metastasis were 68%, 88%, and 15.9%, respectively (30). But CT appears to be relatively accurate in predicting the involvement of the diaphragm and omentum. Additionally, CT has been employed to predict primary cytoreductive outcomes for advanced OC. Axtell et al. demonstrated that the sensitivity and specificity of CT prediction for optimal suboptimal surgical outcome in patients with advanced OC were 79% and 75%, respectively (31). PET/CT has limitations in characterizing ovarian masses, but proves valuable for OC staging and detecting recurrent diseases. Due to limited spatial resolution, PET/CT may struggle to identify peritoneal tumor deposits smaller than 1 cm. Another indication for PET/CT is to detect recurrent diseases. A meta-analysis showed that compared with CT and MRI, PET/CT was relatively accurate in detecting recurrence, with sensitivity and specificity of 91% and 88%, respectively (32). MRI provides excellent tissue differentiation and serve as a problem-solving tool to characterize uncertain lesions observed on CT or ultrasound. In a recent meta-analysis showed that the sensitivity and specificity of MRI in diagnosing OC were 91% and 85%, respectively, surpassing CT and PET/CT in OC detection (33). In a meta-analysis, CT, PET/CT, and MRI were compared for detecting peritoneal metastasis, and MRI showed the highest combined regional sensitivity and specificity, with 92% and 84%, respectively (30). Ultrasound plays an important role in the initial evaluation of adnexal masses and high-risk patients screening. It is recommended to use a vaginal ultrasound morphological scoring system to distinguish between benign and malignant ovarian lesions. The sensitivity and specificity of this system were 100% and 83%, respectively (26). Although ultrasound can be used for diagnose OC, it is not the preferred imaging method for staging OC. In patients with advanced OC, the sensitivity of ultrasound in detecting peritoneal metastasis is relatively low (69%) (34). Research hotspots and frontiers Keyword analysis provides valuable insights into the main research hotspots and directions in the field of OC imaging from 2000 to 2022. Ultrasound emerges as a pivotal focus in OC imaging research, particularly in the initial assessment of adnexal masses and screening individuals with a high risk of OC. RMI based on ultrasonography, menopausal status, and serum CA125 levels can quantitatively assess the risk of malignancy for accurate preoperative diagnosis of OC (25). Analyzing keyword bursts can help researchers in identifying the frontier or future trends in specific fields (35). The keyword with the highest burst intensity is pelvic masses, spanning from 2007 to 2012. During this period, research on pelvic masses mainly focused on evaluating the efficacy of paclitaxel in OC treatment and subsequent follow-up outcomes. Additionally, PET has historically been a prominent avenue in OC imaging with PET/CT proving advantageous in staging, prognostic prediction, response evaluation, and restaging of OC patients (36). MRI has emerged as a research hotspot in the field of OC imaging. MRI has high soft tissue resolution and can be used as a problem-solving tool to characterize uncertain lesions observed on CT or ultrasound (37). MRI not only reduces unnecessary surgical interventions for benign lesions but also minimizes surgeries in inoperable cases, facilitating the initiation of initial chemotherapy treatments for patients and enhancing their overall treatment experience. In recent times, the research community has shown growing interest in keywords such as “HE 4”, “features”, “accuracy”, “apoptosis” and “nanoparticles”, which are indicative of emerging research trends in this particular field and have the potential to become significant areas of investigation in the future. Notably, HE 4 has emerged as a novel biomarker for ovarian cancer. Mi’s research indicates that serum HE4 levels can contribute to diagnosing, evaluating treatment responses, and predicting recurrence in patients with advanced ovarian cancer, fallopian tube cancer, and peritoneal cancer (38). Zhao used CA125 and HE 4 to detect OC, found that the sensitivity of CA125 was higher than that of HE 4 (88.2% vs. 54.7%), while the specificity of HE 4 was higher than that of CA125 (97.9% vs. 67.4%) (39). A prospective multicenter study shown that the risk of ovarian malignancy algorithm based on the CA125 and HE 4 levels can be used to evaluate the risk of epithelial ovarian cancer in premenopausal and postmenopausal women with pelvic masses (40). The term “apoptosis” and “nanoparticles” refers primarily to the targeted therapy associated with OC. In recent years, nanomedicines have been widely used in multiple therapeutic fields, especially in the field of cancer. The use of nanomedicines has greatly improved the safety and efficacy of common anticancer drugs. Nanodrugs have targeted and sustained-release properties. At present, liposomal doxorubicin has been applied in clinical treatment of recurrent platinum resistant OC patients (41). Nanoparticle albumin-bound paclitaxel demonstrated therapeutic efficacy in the treatment of OC, with minimal toxic side effects and improved patient acceptance and compliance (42). The analysis of the keyword timeline, reveals that advancements in imaging and computer technology have significantly enhanced the precision of investigating OC. Furthermore, the evolution of computer science has propelled the growth of artificial intelligence (AI), with radiomics and deep learning emerging as a subfield of AI. Radiomics in OC relies on imaging data for predicting pathological diagnosis, recurrence risk, and treatment prognosis (43, 44). However, the current research on deep learning in OC is still in its preliminary stages (44, 45). Consequently, AI in the domain of OC imaging holds potential as a future development trend. This study has some limitations. First, the search was limited to the WoSCC SCIE database due to software compatibility constraints, potentially resulting in the omission of relevant research findings. Second, the bibliometric analysis conducted using CiteSpace and VOSviewer focused primarily on principal conclusions rather than providing a comprehensive examination of the entire text, limiting the capacity for a systematic review. Third, it is important to note that CiteSpace software does not distinguish between the first author and the corresponding author. Additionally, the presence of multiple authorship identities for the same author may introduce biases in the results related to affiliated institutions. Conclusions The number of publications in OC imaging is gradually increasing with the USA and China being the primary contributors to OC imaging research. Among the authors, Timmerman D from Belgium stands out as the most prolific and highly cited. Gynecologic Oncology is the journal with the highest number of publications and citations in this area. Currently, the main areas of focus in OC imaging research encompass MRI, targeted therapy for OC, novel biomarker (such as HE4), and AI. These areas are expected to shape future research endeavors in the field of OC imaging. Data availability statement The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation. Author contributions YL: Data curation, Formal Analysis, Writing – original draft. SL: Conceptualization, Investigation, Writing – review & editing. JZ: Methodology, Software, Writing – original draft. XW: Data curation, Methodology, Writing – original draft. FL: Formal Analysis, Methodology, Software, Writing – original draft. YW: Investigation, Writing – review & editing. LG: Supervision, Writing – review & editing, Formal Analysis.